Logo image of FLWS

1-800-FLOWERS.COM INC-CL A (FLWS) Stock Fundamental Analysis

NASDAQ:FLWS - Nasdaq - US68243Q1067 - Common Stock - Currency: USD

7.66  -0.55 (-6.7%)

After market: 7.73 +0.07 (+0.91%)

Fundamental Rating

2

FLWS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 120 industry peers in the Specialty Retail industry. While FLWS seems to be doing ok healthwise, there are quite some concerns on its profitability. FLWS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year FLWS has reported negative net income.
FLWS had a positive operating cash flow in the past year.
In multiple years FLWS reported negative net income over the last 5 years.
In the past 5 years FLWS always reported a positive cash flow from operatings.
FLWS Yearly Net Income VS EBIT VS OCF VS FCFFLWS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

With a Return On Assets value of -0.67%, FLWS perfoms like the industry average, outperforming 42.73% of the companies in the same industry.
Looking at the Return On Equity, with a value of -1.54%, FLWS is in line with its industry, outperforming 50.43% of the companies in the same industry.
Industry RankSector Rank
ROA -0.67%
ROE -1.54%
ROIC N/A
ROA(3y)-0.71%
ROA(5y)3.3%
ROE(3y)-1.66%
ROE(5y)6.62%
ROIC(3y)N/A
ROIC(5y)N/A
FLWS Yearly ROA, ROE, ROICFLWS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

FLWS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 40.11%, FLWS is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
In the last couple of years the Gross Margin of FLWS has remained more or less at the same level.
FLWS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.11%
OM growth 3Y-48.39%
OM growth 5Y-23.19%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.7%
GM growth 5Y-0.98%
FLWS Yearly Profit, Operating, Gross MarginsFLWS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

FLWS does not have a ROIC to compare to the WACC, probably because it is not profitable.
FLWS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, FLWS has less shares outstanding
The debt/assets ratio for FLWS has been reduced compared to a year ago.
FLWS Yearly Shares OutstandingFLWS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
FLWS Yearly Total Debt VS Total AssetsFLWS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

FLWS has an Altman-Z score of 2.54. This is not the best score and indicates that FLWS is in the grey zone with still only limited risk for bankruptcy at the moment.
FLWS's Altman-Z score of 2.54 is in line compared to the rest of the industry. FLWS outperforms 55.56% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that FLWS is not too dependend on debt financing.
FLWS has a Debt to Equity ratio (0.32) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 2.54
ROIC/WACCN/A
WACC10.57%
FLWS Yearly LT Debt VS Equity VS FCFFLWS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

FLWS has a Current Ratio of 1.51. This is a normal value and indicates that FLWS is financially healthy and should not expect problems in meeting its short term obligations.
FLWS has a Current ratio (1.51) which is in line with its industry peers.
FLWS has a Quick Ratio of 1.03. This is a normal value and indicates that FLWS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of FLWS (1.03) is better than 76.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.03
FLWS Yearly Current Assets VS Current LiabilitesFLWS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for FLWS have decreased strongly by -150.00% in the last year.
The earnings per share for FLWS have been decreasing by -17.07% on average. This is quite bad
The Revenue has decreased by -7.85% in the past year.
The Revenue has been growing slightly by 7.96% on average over the past years.
EPS 1Y (TTM)-150%
EPS 3Y-52.28%
EPS 5Y-17.07%
EPS Q2Q%-21.26%
Revenue 1Y (TTM)-7.85%
Revenue growth 3Y-4.79%
Revenue growth 5Y7.96%
Sales Q2Q%-5.66%

3.2 Future

FLWS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.66% yearly.
The Revenue is expected to decrease by -0.86% on average over the next years.
EPS Next Y-156.1%
EPS Next 2Y-13.27%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue Next Year-5.79%
Revenue Next 2Y-1.53%
Revenue Next 3Y-0.86%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
FLWS Yearly Revenue VS EstimatesFLWS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
FLWS Yearly EPS VS EstimatesFLWS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FLWS. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 50.91, the valuation of FLWS can be described as expensive.
FLWS's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. FLWS is more expensive than 61.54% of the companies in the same industry.
FLWS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.68.
Industry RankSector Rank
PE N/A
Fwd PE 50.91
FLWS Price Earnings VS Forward Price EarningsFLWS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

FLWS's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.31
FLWS Per share dataFLWS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.27%
EPS Next 3Y0.66%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FLWS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

1-800-FLOWERS.COM INC-CL A

NASDAQ:FLWS (2/21/2025, 8:18:53 PM)

After market: 7.73 +0.07 (+0.91%)

7.66

-0.55 (-6.7%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)01-30 2025-01-30/bmo
Earnings (Next)04-30 2025-04-30/amc
Inst Owners88.8%
Inst Owner Change8.17%
Ins Owners5.67%
Ins Owner Change2.8%
Market Cap487.18M
Analysts80
Price Target10.07 (31.46%)
Short Float %23.68%
Short Ratio10.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.14%
Min EPS beat(2)-17.61%
Max EPS beat(2)3.33%
EPS beat(4)1
Avg EPS beat(4)-10.25%
Min EPS beat(4)-17.61%
Max EPS beat(4)3.33%
EPS beat(8)5
Avg EPS beat(8)1.88%
EPS beat(12)7
Avg EPS beat(12)0.59%
EPS beat(16)10
Avg EPS beat(16)7.99%
Revenue beat(2)0
Avg Revenue beat(2)-5.25%
Min Revenue beat(2)-5.34%
Max Revenue beat(2)-5.16%
Revenue beat(4)0
Avg Revenue beat(4)-4.77%
Min Revenue beat(4)-5.49%
Max Revenue beat(4)-3.11%
Revenue beat(8)1
Avg Revenue beat(8)-3.12%
Revenue beat(12)2
Avg Revenue beat(12)-2.79%
Revenue beat(16)5
Avg Revenue beat(16)-1.41%
PT rev (1m)0%
PT rev (3m)1.16%
EPS NQ rev (1m)-31.43%
EPS NQ rev (3m)-58.36%
EPS NY rev (1m)-164.71%
EPS NY rev (3m)-164.71%
Revenue NQ rev (1m)-4.09%
Revenue NQ rev (3m)-8.09%
Revenue NY rev (1m)-2.96%
Revenue NY rev (3m)-2.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 50.91
P/S 0.28
P/FCF N/A
P/OCF 14.52
P/B 0.98
P/tB 2.18
EV/EBITDA 10.31
EPS(TTM)-0.12
EYN/A
EPS(NY)0.15
Fwd EY1.96%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)0.53
OCFY6.89%
SpS27.64
BVpS7.78
TBVpS3.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.67%
ROE -1.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.11%
FCFM N/A
ROA(3y)-0.71%
ROA(5y)3.3%
ROE(3y)-1.66%
ROE(5y)6.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.61%
ROCE(5y)8.55%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-48.39%
OM growth 5Y-23.19%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.7%
GM growth 5Y-0.98%
F-Score6
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA 3.76
Cap/Depr 81.85%
Cap/Sales 2.49%
Interest Coverage N/A
Cash Conversion 80.01%
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.03
Altman-Z 2.54
F-Score6
WACC10.57%
ROIC/WACCN/A
Cap/Depr(3y)96.72%
Cap/Depr(5y)105.36%
Cap/Sales(3y)2.44%
Cap/Sales(5y)2.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-150%
EPS 3Y-52.28%
EPS 5Y-17.07%
EPS Q2Q%-21.26%
EPS Next Y-156.1%
EPS Next 2Y-13.27%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.85%
Revenue growth 3Y-4.79%
Revenue growth 5Y7.96%
Sales Q2Q%-5.66%
Revenue Next Year-5.79%
Revenue Next 2Y-1.53%
Revenue Next 3Y-0.86%
Revenue Next 5YN/A
EBIT growth 1Y-139.74%
EBIT growth 3Y-50.86%
EBIT growth 5Y-17.07%
EBIT Next Year328.11%
EBIT Next 3Y91.28%
EBIT Next 5YN/A
FCF growth 1Y76.85%
FCF growth 3Y-21.85%
FCF growth 5Y4.38%
OCF growth 1Y156.08%
OCF growth 3Y-18.16%
OCF growth 5Y4%